Skip to content

Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES)

Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02830022
Acronym
APAUTRES
Enrollment
78
Registered
2016-07-12
Start date
2013-12-11
Completion date
2017-06-18
Last updated
2018-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autonomic Nervous System Diseases, Sleep

Keywords

autism spectrum disorder

Brief summary

Autism Spectrum Disorders (ASD) is a neurodevelopmental disorder which involves social and behavioural impairments. Autonomic dysfunctions and disturbed sleep were often associated to ASD. The investigators proposed to explore the impact of physical activity on these disorders. In this context, it is necessary to characterize the cardiorespiratory capacities of ASD children in order to promote physical activity for this population. To examine potential differences between ASD and control children, some explorations were proposed: a maximal treadmill test, motor evaluation, and orthostatic test (for the evaluation of autonomic nervous system). An actimetry during one week (evaluation of physical activity and sleep) completed this study in order to specify sleep characteristic and established the possible link between physical activity sleep characteristics and physical fitness in ASD children.

Interventions

OTHERphysiological explorations

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* children physically active * children with an intellectual quotient \>70 * for autism children a diagnosis of autism in accordance to DSMV

Exclusion criteria

* history of cardio-vascular disease * history of asthma or respiratory disease * Behavior disorders. * medical treatment by neuroleptic or melatonin or antiepileptic

Design outcomes

Primary

MeasureTime frameDescription
cardiorespiratory evaluation1 daya maximal treadmill test is proposed (evaluation of : VO² max, maximal heart rate)
autonomic nervous system evaluation1 day and 3 nightsan orthostatic test is proposed in order to verify the ANS adaptation. A nocturnal recording is made during three nights in order to verify the possible link between the rest autonomic adaptations and a possible dysautonomia observed with the orthostatic test.
sleep evaluation7 nightsSleep characteristics are obtained by an actimetry during 7 nights in order to observe sleep disorders. Sleep Questionnaires are also completed.

Secondary

MeasureTime frameDescription
physical activity7 daysphysical activity characteristics (sedentary, moderate or vigorous activities, energy expenditure) are obtained by an actimetry during 7 days. Questionnaires of physical activity are also completed
biological parameters1 dayduring the maximal treadmill test, salivary samples are made (cortisol, alpha amylase), before and after tthe test
Motor capacities1 daymotor capacities are evaluated by several specific tests : PANESS, M-ABS and Eurofit.
Behavioural characteristics1 hourBehavioural characteristics are evaluated by the Vineland scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026